# Immunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery Patients

> **NCT06565364** · — · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 160 (actual)

## Conditions studied

- Thrombocytopenia
- Antibodies Drug Specific

## Interventions

- **DIAGNOSTIC_TEST:** "ZYMUTEST™ HIA" immunoglobulin g ELISA (enzyme-linked immunosorbent assay )

## Key facts

- **NCT ID:** NCT06565364
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-07
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-03-31
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2024-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06565364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06565364, "Immunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06565364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*